Searched for
AUROBINDO GROUP
Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...- Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
- Stocks in news: SBI Life, Trent, Tata Investment, HCL Tech, Suzlon EnergyIn today's trade, shares of SBI Life, Trent, Tata Investment, HCL Tech, Suzlon Energy among others will be in focus due to various news dev...
- Buyback alert! Last date to buy Aurobindo Pharma shares for Rs 800-crore share buyback. Check detailsAurobindo Pharma has announced an ₹800-crore buyback at ₹1,475 per share, with April 17, 2026 set as the record date—meaning investors must...
- AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
- Market bets on Aurobindo as Europe, US sales show uptickAurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also develop...
- Aurobindo Group's residential unit eyes $225 million India bond issue to fund acquisitionIndia's Auro Realty, the real estate arm of Aurobindo Group which also owns drugmaker Aurobindo Pharma, is planning to raise 20 billion rup...
- Delhi liquor policy case: ED summons K Kavitha again todayKavitha appeared before ED on Monday after the federal agency on March 16, issued a fresh summon to the BRS leader to join its ongoing inve...
- AP clinches investments worth Rs 13 lakh cr at Investors Summit: CM Jagan Mohan ReddySpeaking at the inaugural session of the Global Investors Summit 2023 being held here, Jagan Mohan Reddy said the investment proposals are ...
- Director's arrest no way linked to operations: Aurobindo Pharma"Further to the disclosure of even date, the company further learnt that the arrest of P Sarath Chandra Reddy, whole-time director/promoter...
- Aurobindo in advanced talks with global PE funds, closes in on $1 billion fundraiseAurobindo Pharma is understood to have shortlisted four bulge-bracket global investors - Blackstone Group, Advent International, CVC Capita...
- Aurobindo Pharma arm enters pact to form JV in China with Luoxin"The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin," Aurobindo Pharm...
- Aurobindo buys US units of Sandoz for $900 millionThe acquired business has been carved out by the management of Sandoz for divestment.
- Plethico to pay Aurobindo Pharma $23.3 million to settle disputePlethico USA had not fulfilled obligations while selling Natrol to Aurobindo Pharma USA, hence they have to pay a penalty.
- Aurobindo Pharma Q3 net up 9.81 pc to Rs 188.63 crDrug firm Aurobindo Pharma today said its consolidated net profit rose by 9.81 per cent to Rs 188.63 crore for the third quarter ended Dece...
- Aurobindo: Proceeds from stake sale to beef up cash flowsFrom being a low-margin pharma manufacturer, Aurobindo Pharma is transforming itself into a high-margin formulations player.
- Aurobindo to divest stake in China armGeneric drugmaker Aurobindo Pharma has decided to divest its stake in loss-making Chinese subsidiary , Aurobindo (Datong) Bio Pharma (ADBPL...
Load More
